Sungho Bea

Adherence and Associated Factors of Treatment Regimen in Drug-Susceptible Tuberculosis Patients

Sungho Bea, Hyesung Lee, Ju Hwan Kim et al. · Frontiers in Pharmacology · 2021 · 66 citations · Full text

Public Health, Infectious Disease Control, Clinical Epidemiology +16

Risk of thyroid cancer associated with glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: A population‐based cohort study

Sungho Bea, Heejun Son, Jae Hyun Bae et al. · Diabetes Obesity and Metabolism · 2023 · 61 citations

Medicine, Endocrinology, Pharmacology +16

Risk of hepatic events associated with use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists, and thiazolidinediones among patients with metabolic dysfunction-associated steatotic liver disease

Sungho Bea, Hwa Yeon Ko, Jae Hyun Bae et al. · Gut · 2024 · 48 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study

Han Eol Jeong, Sohee Park, Yunha Noh et al. · BMC Medicine · 2023 · 30 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Sodium–Glucose Cotransporter-2 Inhibitors, Dulaglutide, and Risk for Dementia

Bin Na Hong, Sungho Bea, Hwa Yeon Ko et al. · Annals of Internal Medicine · 2024 · 30 citations

Medicine, Pharmacology, Pharmacotherapy +17